Skip to main content
. Author manuscript; available in PMC: 2015 Nov 7.
Published in final edited form as: Vaccine. 2012 Nov 20;30(0 5):F123–F138. doi: 10.1016/j.vaccine.2012.04.108

Table 8.

Assessment of serious adverse events

Outcome Study Vaccine % Vaccine % Control Relative risk (95% CI)
SAE
FUTURE I Gardasil® 1.8 1.7 1.07 (0.71–1.60)
FUTURE II Gardasil® 0.7 0.9 0.83 (0.56–1.24)
PATRICIA Cervarix® 7.5 7.5 1.00 (0.91–1.11)

Injection-related SAE
FUTURE I Gardasil® 0.03 0.0 3.00 (0.12–73.58)
FUTURE I Gardasil® 0.05 0.03 1.50 (0.25–8.99)
PATRICA Cervarix® 0.12 0.06 1.83 (0.68–4.96)

CI: Confidence interval; SAE: serious adverse event. Data from reference [38].